Bevacizumab chemotherapy for management of pulmonary and laryngotracheal papillomatosis in a child

KB Zur, E Fox - The Laryngoscope, 2017 - Wiley Online Library
Recurrent laryngeal papillomatosis (RRP) can be a devastating condition for a child to
endure, and pulmonary involvement may have terminal consequences. Adjuvant therapies …

Experience with systemic bevacizumab in advanced juvenile recurrent respiratory papillomatosis

K Aggarwal, R Kumar, J Kumari, A Kumar… - Indian Journal of …, 2022 - Springer
Abstract Vascular Endothelial Growth Factor has been demonstrated in squamous
papillomas of Recurrent Respiratory Papillomatosis patients. This case series aimed at …

Treatment of respiratory papillomatosis--a case report on systemic treatment with bevacizumab

S Nagel, C Busch, T Blankenburg… - Pneumologie (Stuttgart …, 2009 - europepmc.org
Background Recurrent respiratory papillomatosis (RRP) is a known but rare disease,
caused by human papilloma virus and characterised by multiple exophytic lesions and …

Trends in recurrent respiratory papillomatosis treatment

SA Ballestas, S Shelly, RM Soriano, A Klein - Acta Otorrinolaringologica …, 2021 - Elsevier
Recurrent respiratory papillomatosis (RRP) consist of benign tumours along the airway
caused by human papillomavirus infection. Papillomas may cause changes in phonation …

Global trends and hotspots on recurrent respiratory papillomatosis: A 20‐year bibliometric analysis

C Wang, Y Pan, H Huang, K Liu… - Laryngoscope …, 2024 - Wiley Online Library
Objectives Recurrent respiratory papillomatosis (RRP) is the most common benign laryngeal
tumor in children. It can cause serious psychological and mental burden on patients since …

Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children

DJ Rogers, S Ojha, R Maurer… - … Otolaryngology–Head & …, 2013 - jamanetwork.com
Importance Juvenile recurrent respiratory papillomatosis (RRP) can be an aggressive
disease process necessitating frequent trips to the operating room with multiple anesthetics …

Use of 532-nm pulsed potassium titanyl phosphate laser and adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children: initial …

S Maturo, CJ Hartnick - Archives of Otolaryngology–Head & Neck …, 2010 - jamanetwork.com
Objective To describe the initial pediatric experience with intralesional bevacizumab
(Avastin) treatment for children with severe, recurrent respiratory papilloma (RRP). Design …

Pharmacotherapy for recurrent respiratory papillomatosis (RRP): a treatment update

AJ Donne, A Kinshuck - Expert Opinion on Pharmacotherapy, 2021 - Taylor & Francis
Introduction: Recurrent respiratory papillomatosis is a rare human papillomavirus (HPV)-
induced condition where warts grow within the airway and especially the larynx to effect …

Office-based management of recurrent respiratory papilloma

KM Motz, AT Hillel - Current otorhinolaryngology reports, 2016 - Springer
This review will highlight the indications and benefits of office-based therapy for recurrent
respiratory papillomatosis (RRP) and discuss the utilization of photodynamic lasers and …

Laryngotracheal Recurrent Papillomatosis: A Case Study and Survey of Surgical and Systemic Management

M Borrelli, T Nasrollahi, J Raskin… - Ear, Nose & Throat …, 2022 - journals.sagepub.com
This case report presents a 72-year-old man with longstanding recurrent respiratory
papillomatosis (RRP). He has undergone multiple procedures for the condition, including an …